About this Journal Submit a Manuscript Table of Contents
Hepatitis Research and Treatment
Volume 2010 (2010), Article ID 205128, 10 pages
http://dx.doi.org/10.1155/2010/205128
Review Article

Biliary Epithelial Apoptosis, Autophagy, and Senescence in Primary Biliary Cirrhosis

Department of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa 920-8640, Japan

Received 28 August 2010; Accepted 5 October 2010

Academic Editor: Annarosa Floreani

Copyright © 2010 Motoko Sasaki and Yasuni Nakanuma. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. E. Gershwin, I. R. Mackay, A. Sturgess, and R. L. Coppel, “Identification and specificity of a cDNA encoding the 70 KD mitochondrial antigen recognized in primary biliary cirrhosis,” Journal of Immunology, vol. 138, no. 10, pp. 3525–3531, 1987. View at Scopus
  2. M. M. Kaplan and M. E. Gershwin, “Primary biliary cirrhosis,” The New England Journal of Medicine, vol. 353, no. 12, pp. 1261–1273, 2005. View at Publisher · View at Google Scholar · View at PubMed
  3. B. Portmann and Y. Nakanuma, “Diseases of the bile ducts,” in Pathology of the Liver, R. MacSween, A. Burt, B. C. Portmann, K. Ishak, P. Scheuer, and P. Anthony, Eds., pp. 435–506, Churchill Livingstone, London, UK, 4th edition, 2001.
  4. M. E. Gershwin and I. R. Mackay, “The causes of primary biliary cirrhosis: convenient and inconvenient truths,” Hepatology, vol. 47, no. 2, pp. 737–745, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. Sasaki, A. Ansari, N. Pumford et al., “Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: searching for a mimic,” Journal of Autoimmunity, vol. 15, no. 1, pp. 51–60, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. Y. Nakanuma and G. Ohta, “Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis,” Gastroenterology, vol. 76, no. 6, pp. 1326–1332, 1979. View at Scopus
  7. J. Van de Water, M. E. Gershwin, P. Leung, A. Ansari, and R. L. Coppel, “The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase,” Journal of Experimental Medicine, vol. 167, no. 6, pp. 1791–1799, 1988. View at Scopus
  8. P. S. C. Leung, D. T. Chuang, R. M. Wynn et al., “Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope,” Hepatology, vol. 22, no. 2, pp. 505–513, 1995. View at Scopus
  9. C. D. Surh, R. Coppel, and M. E. Gershwin, “Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope,” Journal of Immunology, vol. 144, no. 9, pp. 3367–3374, 1990. View at Scopus
  10. S. P. M. Fussey, J. R. Guest, O. F. W. James, M. F. Bassendine, and S. J. Yeaman, “Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 22, pp. 8654–8658, 1988. View at Scopus
  11. H. Kita, Z.-X. Lian, J. Van De Water et al., “Identification of HLA-A2-restricted CD8+ cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells,” Journal of Experimental Medicine, vol. 195, no. 1, pp. 113–123, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Shimoda, J. Van De Water, A. Ansari et al., “Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis,” Journal of Clinical Investigation, vol. 102, no. 10, pp. 1831–1840, 1998. View at Scopus
  13. T. Kamihira, S. Shimoda, K. Harada et al., “Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis,” Gastroenterology, vol. 125, no. 5, pp. 1379–1387, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Liu, P. Invernizzi, Y. Lu et al., “Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis,” Nature Genetics, vol. 42, no. 8, pp. 658–660, 2010. View at Publisher · View at Google Scholar · View at PubMed
  15. G. M. Hirschfield, X. Liu, C. Xu et al., “Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants,” The New England Journal of Medicine, vol. 360, no. 24, pp. 2544–2555, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. P. Invernizzi, M. Miozzo, P. M. Battezzati et al., “Frequency of monosomy X in women with primary biliary cirrhosis,” The Lancet, vol. 363, no. 9408, pp. 533–535, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. P. Invernizzi and M. E. Gershwin, “The genetics of human autoimmune disease,” Journal of Autoimmunity, vol. 33, pp. 290–299, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. M. E. Gershwin, C. Selmi, H. J. Worman et al., “Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients,” Hepatology, vol. 42, no. 5, pp. 1194–1202, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. C. Selmi, D. L. Balkwill, P. Invernizzi et al., “Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium,” Hepatology, vol. 38, no. 5, pp. 1250–1257, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. S. A. Long, C. Quan, J. Van de Water et al., “Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis,” Journal of Immunology, vol. 167, no. 5, pp. 2956–2963, 2001. View at Scopus
  21. A. Lleo, C. L. Bowlus, G.-X. Yang et al., “Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis,” Hepatology, vol. 52, no. 3, pp. 987–996, 2010. View at Publisher · View at Google Scholar · View at PubMed
  22. A. Lleo, C. Selmi, P. Invernizzi et al., “Apotopes and the biliary specificity of primary biliary cirrhosis,” Hepatology, vol. 49, no. 3, pp. 871–879, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. J. A. Odin, R. C. Huebert, L. Casciola-Rosen, N. F. LaRusso, and A. Rosen, “Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis,” Journal of Clinical Investigation, vol. 108, no. 2, pp. 223–232, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Sasaki, H. Ikeda, H. Haga, T. Manabe, and Y. Nakanuma, “Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss,” Journal of Pathology, vol. 205, no. 4, pp. 451–459, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. M. Sasaki, H. Ikeda, and Y. Nakanuma, “Activation of ATM signaling pathway is involved in oxidative stress-induced expression of mito-inhibitory p21WAF1/Cip1 in chronic non-suppurative destructive cholangitis in primary biliary cirrhosis: an immunohistochemical study,” Journal of Autoimmunity, vol. 31, no. 1, pp. 73–78, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. M. Sasaki, H. Ikeda, Y. Sato, and Y. Nakanuma, “Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis,” American Journal of Pathology, vol. 169, no. 3, pp. 831–845, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Sasaki, H. Ikeda, J. Yamaguchi, S. Nakada, and Y. Nakanuma, “Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence,” Hepatology, vol. 48, no. 1, pp. 186–195, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. M. Sasaki, M. Miyakoshi, Y. Sato, and Y. Nakanuma, “Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis,” Laboratory Investigation, vol. 90, no. 6, pp. 835–843, 2010. View at Publisher · View at Google Scholar · View at PubMed
  29. M. Sasaki, M. Miyakoshi, Y. Sato, and Y. Nakanuma, “Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis,” Journal of Hepatology, vol. 53, no. 2, pp. 318–325, 2010. View at Publisher · View at Google Scholar · View at PubMed
  30. A. Nishio, J. Van De Water, P. S. C. Leung et al., “Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis,” Hepatology, vol. 25, no. 5, pp. 1085–1089, 1997. View at Scopus
  31. P. Invernizzi, A. Crosignani, P. M. Battezzati et al., “Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis,” Hepatology, vol. 25, no. 5, pp. 1090–1095, 1997. View at Scopus
  32. G. D. Benson, K. Kikuchi, H. Miyakawa, A. Tanaka, M. R. Watnik, and M. E. Gershwin, “Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis,” Clinical and Developmental Immunology, vol. 11, no. 2, pp. 129–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. E. J. Heathcote, “Management of primary biliary cirrhosis,” Hepatology, vol. 31, no. 4, pp. 1005–1013, 2000.
  34. O. Bandin, J.-C. Courvalin, R. Poupon, L. Dubel, J.-C. Homberg, and C. Johanet, “Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis,” Hepatology, vol. 23, no. 5, pp. 1020–1024, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Wesierska-Gadek, H. Hohenauer, E. Hitchman, and E. Penner, “Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis,” Gastroenterology, vol. 110, no. 3, pp. 840–847, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Nakamura, H. Kondo, T. Mori et al., “Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis,” Hepatology, vol. 45, no. 1, pp. 118–127, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. B. Portmann and Y. Nakanuma, “Diseases of the bile ducts,” in Pathology of the Liver, A. Burt, B. C. Portmann, and L. D. Farrell, Eds., pp. 517–581, Churchill Livingstone, London, UK, 5th edition, 2007.
  38. Y. Nakanuma, Y. Zen, K. Harada et al., “Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: interobserver agreement,” Pathology International, vol. 60, no. 3, pp. 167–174, 2010. View at Publisher · View at Google Scholar · View at PubMed
  39. S. Shimoda, K. Harada, H. Niiro et al., “Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells,” Hepatology, vol. 47, no. 3, pp. 958–965, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. J. Allina, B. Hu, D. M. Sullivan et al., “T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis,” Journal of Autoimmunity, vol. 27, no. 4, pp. 232–241, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. A. Lleo, P. Invernizzi, C. Selmi et al., “Autophagy: highlighting a novel player in the autoimmunity scenario,” Journal of Autoimmunity, vol. 29, no. 2-3, pp. 61–68, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. M. Sasaki, A. A. Ansari, Y. Nakanuma, R. L. Coppel, E. B. Keeffe, and M. E. Gershwin, “The immunopathology of primary biliary cirrhosis: thoughts for the millennium,” Archivum Immunologiae et Therapiae Experimentalis, vol. 48, no. 1, pp. 1–10, 2000. View at Scopus
  43. M. Sasaki, Y. Nakanuma, S. B. Ho, and Y. S. Kim, “Increased MUC6 apomucin expression is a characteristic of reactive biliary epithelium in chronic viral hepatitis,” Journal of Pathology, vol. 185, no. 2, pp. 191–198, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Ohira, M. Sasaki, K. Harada et al., “Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-α and stromal-derived factor-1 released in stroma,” American Journal of Pathology, vol. 168, no. 4, pp. 1155–1168, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Ishikawa, M. Sasaki, S. Ohira et al., “Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis,” Laboratory Investigation, vol. 84, no. 5, pp. 629–638, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. K. Kaji, Y. Nakanuma, M. Sasaki et al., “Hepatitic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies,” Modern Pathology, vol. 7, no. 9, pp. 937–945, 1994. View at Scopus
  47. M. Yasoshima, N. Kono, H. Sugawara, K. Katayanagi, K. Harada, and Y. Nakanuma, “Increased expression of interleukin-6 and tumor necrosis factor-α in pathologic biliary epithelial cells: in situ and culture study,” Laboratory Investigation, vol. 78, no. 1, pp. 89–100, 1998. View at Scopus
  48. D. H. Adams, S. G. Hubscher, J. Shaw et al., “Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis,” Hepatology, vol. 14, no. 3, pp. 426–431, 1991. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Tsuneyama, J. Van de Water, P. S. C. Leung et al., “Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression,” Hepatology, vol. 21, no. 4, pp. 1031–1037, 1995. View at Scopus
  50. R. C. S. Ayres, J. M. Neuberger, J. Shaw, R. Joplin, and D. H. Adams, “Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines,” Gut, vol. 34, no. 9, pp. 1245–1249, 1993. View at Scopus
  51. D. F. Jelinek and P. E. Lipsky, “Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-α and interleukin 11,” Journal of Immunology, vol. 139, no. 9, pp. 2970–2976, 1987. View at Scopus
  52. K. Matsumoto, H. Fujii, G. Michalopoulos, J. J. Fung, and A. J. Demetris, “Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro,” Hepatology, vol. 20, no. 2, pp. 376–382, 1994. View at Publisher · View at Google Scholar · View at Scopus
  53. R. González-Amaro, C. García-Monzón, L. García-Buey et al., “Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis,” Journal of Experimental Medicine, vol. 179, no. 3, pp. 841–848, 1994. View at Scopus
  54. Y. Mano, M. Ishii, H. Okamoto, T. Igarashi, K. Kobayashi, and T. Toyota, “Effect of tumor necrosis factor α on intrahepatic bile duct epithelial cells of rat liver,” Hepatology, vol. 23, no. 6, pp. 1602–1607, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. K. Isse, K. Harada, Y. Zen et al., “Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts,” Hepatology, vol. 41, no. 3, pp. 506–516, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. K. Tsuneyama, K. Harada, M. Yasoshima et al., “Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: Implications for pathologenesis,” Journal of Pathology, vol. 193, no. 1, pp. 102–109, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. Y.-H. Chuang, Z.-X. Lian, C.-M. Cheng et al., “Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives,” Journal of Autoimmunity, vol. 25, no. 2, pp. 126–132, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. M. Sasaki, H. Ikeda, and Y. Nakanuma, “Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance,” Progress in Histochemistry and Cytochemistry, vol. 42, no. 2, pp. 61–110, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. M. Sasaki, H. Ikeda, S. Ohira, A. Ishikawa, and Y. Nakanuma, “Expression of trefoil factor family 1, 2, and 3 peptide is augmented in hepatolithiasis,” Peptides, vol. 25, no. 5, pp. 763–770, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. M. Sasaki and Y. Nakanuma, “Abnormal expression of MUC1 apomucin and mature MUC1 mucin in biliary epithelial cells in various cystic liver diseases,” Hepatology, vol. 24, no. 3, pp. 539–543, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. G. Srivatsa, A. S. Giraud, M. Ulaganathan, N. D. Yeomans, C. Dow, and A. J. Nicoll, “Biliary epithelial trefoil peptide expression is increased in biliary diseases,” Histopathology, vol. 40, no. 3, pp. 261–268, 2002. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Kimura, P. S. C. Leung, T. P. Kenny et al., “Differential expression of intestinal trefoil factor in biliary epithelial cells of primary biliary cirrhosis,” Hepatology, vol. 36, no. 5, pp. 1227–1235, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. I. Nozaki, J. G. Lunz III, S. Specht et al., “Regulation and function of trefoil factor family 3 expression in the biliary tree,” American Journal of Pathology, vol. 165, no. 6, pp. 1907–1920, 2004. View at Scopus
  64. E. White and S. W. Lowe, “Eating to exit: autophagy-enabled senescence revealed,” Genes and Development, vol. 23, no. 7, pp. 784–787, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. N. Mizushima, “Autophagy: process and function,” Genes and Development, vol. 21, no. 22, pp. 2861–2873, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. X.-M. Yin, W.-X. Ding, and W. Gao, “Autophagy in the liver,” Hepatology, vol. 47, no. 5, pp. 1773–1785, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. B. Levine and G. Kroemer, “Autophagy in the pathogenesis of disease,” Cell, vol. 132, no. 1, pp. 27–42, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. A. R. J. Young, M. Narita, M. Ferreira et al., “Autophagy mediates the mitotic senescence transition,” Genes and Development, vol. 23, no. 7, pp. 798–803, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. H. Koga, S. Sakisaka, M. Ohishi, M. Sata, and K. Tanikawa, “Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis,” Hepatology, vol. 25, no. 5, pp. 1077–1084, 1997. View at Scopus
  70. T. Kuroki, S. Seki, N. Kawakita et al., “Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis,” Virchows Archiv, vol. 429, no. 2-3, pp. 119–129, 1996. View at Scopus
  71. N. Mizushima, B. Levine, A. M. Cuervo, and D. J. Klionsky, “Autophagy fights disease through cellular self-digestion,” Nature, vol. 451, no. 7182, pp. 1069–1075, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. Y. Ohsumi, “Molecular dissection of autophagy: two ubiquitin-like systems,” Nature Reviews Molecular Cell Biology, vol. 2, no. 3, pp. 211–216, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. Y. Kabeya, N. Mizushima, T. Ueno et al., “LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing,” EMBO Journal, vol. 19, no. 21, pp. 5720–5728, 2000. View at Scopus
  74. V. Menéndez-Benito and J. Neefjes, “Autophagy in MHC class II presentation: sampling from within,” Immunity, vol. 26, no. 1, pp. 1–3, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. H.-J. Anders and D. O. Schlondorff, “Innate immune receptors and autophagy: implications for autoimmune kidney injury,” Kidney International, vol. 78, no. 1, pp. 29–37, 2010. View at Publisher · View at Google Scholar · View at PubMed
  76. S. H. Sigal, P. Rajvanshi, G. R. Gorla et al., “Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events,” American Journal of Physiology, vol. 276, no. 5, pp. G1260–G1272, 1999. View at Scopus
  77. W. Brodsky Ya. and I. V. Uryvaeva, “Cell polyploidy: its relation to tissue growth and function,” International Review of Cytology, vol. 50, pp. 275–332, 1977. View at Scopus
  78. G. P. Dimri, X. Lee, G. Basile et al., “A biomarker that identifies senescent human cells in culture and in aging skin in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 20, pp. 9363–9367, 1995. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Collado, M. A. Blasco, and M. Serrano, “Cellular senescence in cancer and aging,” Cell, vol. 130, no. 2, pp. 223–233, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. M. Braig, S. Lee, C. Loddenkemper et al., “Oncogene-induced senescence as an initial barrier in lymphoma development,” Nature, vol. 436, no. 7051, pp. 660–665, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. V. Krizhanovsky, M. Yon, R. A. Dickins et al., “Senescence of activated stellate cells limits liver fibrosis,” Cell, vol. 134, no. 4, pp. 657–667, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. J. G. Lunz III, S. Contrucci, K. Ruppert et al., “Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21WAF1/Cip1 as a disease marker and the influence of immunosuppressive drugs,” American Journal of Pathology, vol. 158, no. 4, pp. 1379–1390, 2001. View at Scopus
  83. V. Paradis, N. Youssef, D. Dargère et al., “Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas,” Human Pathology, vol. 32, no. 3, pp. 327–332, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. S. U. Wiemann, A. Satyanarayana, M. Tsahuridu et al., “Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis,” FASEB Journal, vol. 16, no. 9, pp. 935–942, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. R. R. Plentz, Y. N. Park, A. Lechel et al., “Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis,” Hepatology, vol. 45, no. 4, pp. 968–976, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. R. R. Plentz, B. Schlegelberger, P. Flemming et al., “Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma,” Hepatology, vol. 42, no. 3, pp. 522–526, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  87. M. Serrano and M. A. Blasco, “Putting the stress on senescence,” Current Opinion in Cell Biology, vol. 13, no. 6, pp. 748–753, 2001. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Demetris, “Immunopathology of the human biliary tree,” in Biliary and Pancreatic Pancreatic Ductal Epithelia, A. Sirica and D. Longnecker, Eds., pp. 127–180, Marcel Dekker, New York, NY, USA, 1997.
  89. J. C. Acosta, A. O'Loghlen, A. Banito et al., “Chemokine signaling via the CXCR2 receptor reinforces senescence,” Cell, vol. 133, no. 6, pp. 1006–1018, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. T. Kuilman, C. Michaloglou, L. C. W. Vredeveld et al., “Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network,” Cell, vol. 133, no. 6, pp. 1019–1031, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. N. Wajapeyee, R. W. Serra, X. Zhu, M. Mahalingam, and M. R. Green, “Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7,” Cell, vol. 132, no. 3, pp. 363–374, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. D. N. Shelton, E. Chang, P. S. Whittier, D. Choi, and W. D. Funk, “Microarray analysis of replicative senescence,” Current Biology, vol. 9, no. 17, pp. 939–945, 1999. View at Publisher · View at Google Scholar · View at Scopus
  93. J.-P. Coppé, C. K. Patil, F. Rodier et al., “Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor,” PLoS Biology, vol. 6, no. 12, pp. 2853–2868, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. D. Alvaro, M. G. Mancino, S. Glaser et al., “Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver,” Gastroenterology, vol. 132, no. 1, pp. 415–431, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus